-+ 0.00%
-+ 0.00%
-+ 0.00%

DKSH to Buy NewBridge Pharmaceuticals for $390 Million

MT Newswires·10/19/2026 01:34:14
Listen to the news
01:34 AM EDT, 10/19/2026 (MT Newswires) -- DKSH (DKSH.SW) agreed to buy Dubai-based healthcare commercialization platform NewBridge Pharmaceuticals at an enterprise value of $390 million, according to a Monday release. The Swiss distribution company said the acquisition will pave the way for setting up a healthcare platform in the Middle East, considering NewBridge's existing operations in the Middle East and North Africa region. Completion of the acquisition is expected by the end of the first quarter of 2027, subject to regulatory approvals, among other closing conditions.